RY1 Activators
RY1 Activators are diversified compounds that enhance the functional activity of the protein RY1 through distinct signaling mechanisms and cellular processes. Forskolin, through adenylyl cyclase activation, increases intracellular cAMP, which in turn activates PKA. PKA can phosphorylate and activate RY1 if it possesses a phosphorylation site for PKA or isinvolved in cAMP-dependent pathways. Likewise, IBMX sustains elevated levels of cAMP by inhibiting phosphodiesterases, thus prolonging PKA's activating influence on RY1. EGCG, by inhibiting kinase activity, may alleviate negative regulatory influences on RY1, resulting in its enhanced activation, assuming RY1 is negatively regulated by these kinases. Ionomycin and A23187, both increase intracellular calcium levels, potentially activating RY1 if it is calcium-sensitive or involved in calcium-dependent signaling pathways. PMA activates PKC which might directly phosphorylate RY1 or activate it through PKC-dependent pathways, while LY294002 inhibits PI3K, potentially reducing inhibitory signals and favoring RY1 activation if RY1 is regulated by PI3K signaling. PD98059's inhibition of MEK could lead to RY1 activation due to reduced ERK activity, suggesting a negative feedback loop where ERK activity inhibits RY1 function.
Sildenafil and Zaprinast raise cGMP levels by inhibiting PDE5, which may lead to the activation of RY1 if it is regulated by cGMP-dependent kinases or pathways. Sodium Butyrate, by promoting a more relaxed chromatin structure, may indirectly enhance RY1 activity through increased transcription of the RY1 gene, assuming that RY1's functional activity is sensitive to its expression levels. Lastly, BAPTA-AM, by chelating intracellular calcium, can modulate calcium-dependent processes; if RY1 is activated by such a feedback mechanism, BAPTA-AM could indirectly lead to its activation. Thus, these chemical compounds, each affecting a unique aspect of cellular signaling, have the potential to enhance the functional activity of RY1 through specific and diverse biochemical pathways.
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin activates adenylyl cyclase, increasing cAMP levels in the cell. If RY1 is a protein that is regulated by cAMP-dependent pathways, the rise in cAMP would lead to the activation of protein kinase A (PKA), which could then phosphorylate RY1, increasing its functional activity. | ||||||
IBMX | 28822-58-4 | sc-201188 sc-201188B sc-201188A | 200 mg 500 mg 1 g | $260.00 $350.00 $500.00 | 34 | |
IBMX is a non-selective inhibitor of phosphodiesterases, which degrade cAMP. By preventing cAMP breakdown, IBMX can sustain PKA activation. If RY1 activity is modulated by PKA, IBMX would enhance RY1's activity by maintaining elevated PKA activity. | ||||||
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $43.00 $73.00 $126.00 $243.00 $530.00 $1259.00 | 11 | |
EGCG is a known inhibitor of certain protein kinases. If RY1 is activated by a pathway that is negatively regulated by one of these kinases, EGCG may release the inhibitory effect on RY1, thus enhancing its activity. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $78.00 $270.00 | 80 | |
Ionomycin is a calcium ionophore that increases intracellular calcium levels. If RY1 is part of a signaling pathway that is calcium-dependent, the elevated calcium levels could lead to RY1 activation. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA is an activator of protein kinase C (PKC). If RY1 is activated by PKC or is part of a pathway downstream of PKC, PMA would enhance RY1's functional activity by activating PKC. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002 is an inhibitor of PI3K. If RY1 operates downstream of PI3K or is negatively regulated by pathways involving PI3K, inhibition by LY294002 could shift the balance towards RY1 activation. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
PD98059 is an inhibitor of MEK, which is upstream of ERK in the MAPK pathway. If RY1 is activated as a result of reduced ERK activity, PD98059 would enhance RY1 activity by inhibiting MEK. | ||||||
A23187 | 52665-69-7 | sc-3591 sc-3591B sc-3591A sc-3591C | 1 mg 5 mg 10 mg 25 mg | $55.00 $131.00 $203.00 $317.00 | 23 | |
A23187 is another calcium ionophore. If RY1's activity is calcium-dependent, A23187 would enhance RY1 activity by elevating intracellular calcium levels. | ||||||
Sodium Butyrate | 156-54-7 | sc-202341 sc-202341B sc-202341A sc-202341C | 250 mg 5 g 25 g 500 g | $31.00 $47.00 $84.00 $222.00 | 19 | |
Sodium butyrate is a histone deacetylase inhibitor which can lead to a more relaxed chromatin structure and potentially increase gene expression. If RY1 activity is enhanced by a greater availability of its protein due to increased transcription, sodium butyrate could indirectly enhance RY1 activity. | ||||||
Zaprinast (M&B 22948) | 37762-06-4 | sc-201206 sc-201206A | 25 mg 100 mg | $105.00 $250.00 | 8 | |
Zaprinast is a PDE5 inhibitor like sildenafil and also increases cGMP levels. If RY1 is regulated by cGMP-dependent protein kinases, zaprinast could enhance RY1 activity similarly to sildenafil. | ||||||